Table 3. Genotype frequencies of mTOR rs2295080 polymorphism in breast cancers and controls.

Model	Genotype	Case (n, %)	Control (n, %)	OR (95% CI)	P-value
Codominant	T/T	351 (62.7%)	345 (59.2%)	1.00
	G/T	197 (35.2%)	212 (36.4%)	0.91 (0.72–1.17)
	G/G	12 (2.1%)	26 (4.4%)	0.45 (0.23–0.91)	0.02
Dominant	T/T	351 (62.7%)	345 (59.2%)	1.00
	G/T–G/G	209 (37.3%)	238 (40.8%)	0.86 (0.68–1.09)	0.23
Recessive	T/T–G/T	548 (97.9%)	557 (95.9%)	1.00
	G/G	12 (2.1%)	26 (4.4%)	0.47 (0.23–0.94)	0.03
Overdominant	T/T–G/G	363 (64.8%)	371 (63.6%)	1.00
	G/T	197 (35.2%)	212 (36.4%)	0.95 (0.75–1.21)	0.68
Allele	T	899(80.3%)	902 (77.4%)	1.00
	G	221(19.7%)	264 (22.6%)	0.84 (0.69–1.03)	0.04